Deck Kelly
SEC insider (Form 3/4/5 filer). CIK 0001819427. Chief Financial Officer at Inhibrx Biosciences, Inc. (INBX). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 1, 2025. Located in LA JOLLA, CA.
Companies Deck Kelly has filed insider reports for
- Inhibrx Biosciences, Inc. (INBX): Officer, Chief Financial Officer
Deck Kelly
CIK: 0001819427
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INBX
Inhibrx Biosciences, Inc.
Officer